Archiv
A zymogen-like factor Xa variant corrects the coagulation defect in hemophilia.
http://www.ncbi.nlm.nih.gov/pubmed/22020385?dopt=Abstract[more]
Hepatitis C Bigger Killer than HIV
More Americans now die from hepatitis C infection than from HIV, researchers from the Centers for Disease Control and Prevention reported.full story [more]
Model Explains Efficacy of HIV Drugs
Model Explains Efficacy of HIV DrugsAny HIV therapy that reduces the risk of an immune cell being infected by a factor of at least 100,000 is enough to keep the virus in check, researchers reported. full story Source:...[more]
First patient screened in CSL Behring global Phase I/III study of recombinant single-chain factor VIII
http://www.cslbehring.com/news-room/rVIII-SingleChain-Screens-First-Patient-in-Phase-I/III-Study[more]
PROLOR BIOTECH TO PRESENT PRECLINICAL DATA ON ITS LONG-ACTING CLOTTING FACTORS VIIa and IX AT EUROPEAN HEMOPHILIA CONFERENCE
http://www.prolor-biotech.com/_Uploads/dbsAttachedFiles/NewsPROLORToPresentFactorVIIa-CTPDataAtEuropeanHemophiliaConference.pdf[more]
Hard-to-Treat Group Trips Up HCV Drug
A promising hepatitis C medication has run into a roadblock in a small group of hard-to-treat patients, according to the drug’s maker. full story Source: medpagetoday[more]
Individual prions capable of cell damage
Individual prions capable of cell damageNew research published online in the journal Proceedings of the National Academy of Sciences challenges the concept that neural degeneration is the result of prion aggregates, also called...[more]